hepatitis c
Counting The Cost: Hepatitis C Treatment In Asia
How should decisions about the cost effectiveness of hepatitis C treatments be made? Rebecca Tan finds out what the experts think at the inaugural Singapore Hepatitis Conference held at Suntec Singapore Convention and Exhibition Center from 6-7 June 2014.
WHO Issues First Hepatitis C Guidelines
The recommendations include increasing hepatitis C screening, liver damage mitigation and how to select appropriate treatment for chronic infections.
Antiviral Therapy For Hep C Improved Diabetes Outcomes
Research from Taiwan has shown that antiviral therapy for hepatitis C virus improved kidney and cardiovascular outcomes for patients with diabetes.
WHO Urges Action On Hepatitis Threat
The World Health Organization has urged governments to act against the five hepatitis viruses that can cause severe liver infections.
BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China
BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.
Roche, Ascletis To Bring Hepatitis C Drug Danoprevir Into China
Roche and Ascletis have entered into a collaboration to develop and commercialize Roche's investigational Hepatitis C drug danoprevir in China.
Watching Evolution In Real-Time
Scientists have developed a method to study the evolution of microbes and cancer cells by detecting mutations as they happen.
PerkinElmer Acquires Chinese Infectious Disease Diagnostics Company
PerkinElmer has acquired Shanghai Haoyuan Biotech to extend its reach into the growing Chinese nucleic acid-based blood screening market.
Bristol-Myers Squibb Awards Four Grants For Hepatitis Education
To mark World Hepatitis Day 2012, the Bristol-Myers Squibb Foundation has awarded four new grants focused on Hepatitis B and Hepatitis C research in China and India.
